X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (61475) 61475
Book Review (10160) 10160
Publication (3735) 3735
Book / eBook (153) 153
Conference Proceeding (102) 102
Book Chapter (48) 48
Magazine Article (34) 34
Newsletter (30) 30
Dissertation (25) 25
Transcript (18) 18
Newspaper Article (13) 13
Data Set (3) 3
Paper (3) 3
Trade Publication Article (3) 3
Reference (2) 2
Report (2) 2
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (59802) 59802
index medicus (58179) 58179
female (41846) 41846
antineoplastic combined chemotherapy protocols - therapeutic use (38017) 38017
male (34584) 34584
middle aged (34581) 34581
oncology (33695) 33695
antineoplastic combined chemotherapy protocols - adverse effects (30016) 30016
aged (29520) 29520
adult (28666) 28666
chemotherapy (22175) 22175
treatment outcome (17388) 17388
cancer (17376) 17376
antineoplastic combined chemotherapy protocols - administration & dosage (9920) 9920
combined modality therapy (8880) 8880
aged, 80 and over (8605) 8605
care and treatment (8400) 8400
cisplatin - administration & dosage (8349) 8349
neoplasm staging (8248) 8248
disease-free survival (8106) 8106
hematology (8080) 8080
therapy (7707) 7707
drug administration schedule (7477) 7477
adolescent (7007) 7007
antineoplastic agents - therapeutic use (6992) 6992
fluorouracil - administration & dosage (6967) 6967
prognosis (6881) 6881
breast neoplasms - drug therapy (6798) 6798
survival rate (6780) 6780
medicine & public health (6378) 6378
retrospective studies (6252) 6252
cisplatin (6245) 6245
survival analysis (6126) 6126
antineoplastic agents - adverse effects (5846) 5846
lung neoplasms - drug therapy (5842) 5842
survival (5566) 5566
follow-up studies (5507) 5507
cyclophosphamide - administration & dosage (5413) 5413
research (5322) 5322
pharmacology & pharmacy (5286) 5286
doxorubicin - administration & dosage (5234) 5234
trial (5210) 5210
radiotherapy (4830) 4830
abridged index medicus (4623) 4623
dose-response relationship, drug (4622) 4622
hematology, oncology and palliative medicine (4571) 4571
child (4553) 4553
antineoplastic agents (4534) 4534
carcinoma (4460) 4460
cisplatin - adverse effects (4356) 4356
analysis (4341) 4341
deoxycytidine - analogs & derivatives (4330) 4330
animals (4275) 4275
antineoplastic agents - administration & dosage (4242) 4242
drug therapy (4133) 4133
breast cancer (4072) 4072
prospective studies (4063) 4063
chemotherapy, adjuvant (4052) 4052
antimitotic agents (4041) 4041
remission induction (4001) 4001
clinical trials (3963) 3963
risk factors (3931) 3931
neoplasms - drug therapy (3918) 3918
health aspects (3866) 3866
carcinoma, non-small-cell lung - drug therapy (3741) 3741
surgery (3685) 3685
fluorouracil - adverse effects (3680) 3680
deoxycytidine - administration & dosage (3666) 3666
paclitaxel - administration & dosage (3660) 3660
time factors (3639) 3639
metastasis (3601) 3601
neoplasm metastasis (3591) 3591
toxicity (3584) 3584
young adult (3569) 3569
tumors (3460) 3460
etoposide - administration & dosage (3443) 3443
paclitaxel (3412) 3412
combination (3393) 3393
vincristine - administration & dosage (3344) 3344
child, preschool (3309) 3309
fluorouracil (3272) 3272
carboplatin - administration & dosage (3249) 3249
breast neoplasms - pathology (3225) 3225
adenocarcinoma - drug therapy (3076) 3076
cyclophosphamide - adverse effects (3026) 3026
cyclophosphamide (3011) 3011
doxorubicin - adverse effects (2996) 2996
colorectal neoplasms - drug therapy (2978) 2978
clinical trials as topic (2957) 2957
kaplan-meier estimate (2931) 2931
disease progression (2916) 2916
phase-ii (2830) 2830
docetaxel (2809) 2809
doxorubicin (2741) 2741
neutropenia - chemically induced (2632) 2632
gemcitabine (2621) 2621
5-fluorouracil (2615) 2615
carboplatin (2605) 2605
leucovorin - administration & dosage (2569) 2569
recurrence (2569) 2569
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (119) 119
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Online Resources - Online (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Chemistry (A D Allen) - Stacks (2) 2
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (57058) 57058
Japanese (1689) 1689
German (816) 816
French (575) 575
Chinese (550) 550
Russian (296) 296
Spanish (247) 247
Italian (124) 124
Polish (121) 121
Hungarian (83) 83
Dutch (42) 42
Czech (24) 24
Danish (15) 15
Portuguese (13) 13
Hebrew (11) 11
Norwegian (11) 11
Romanian (10) 10
Serbian (10) 10
Korean (9) 9
Ukrainian (9) 9
Bulgarian (7) 7
Swedish (7) 7
Croatian (5) 5
Finnish (4) 4
Slovak (4) 4
Bosnian (3) 3
Turkish (3) 3
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 06/2017, Volume 317, Issue 23, pp. 2392 - 2401
IMPORTANCE: Combining biologic monoclonal antibodies with chemotherapeutic cytotoxic drugs provides clinical benefit to patients with advanced or metastatic... 
MEDICINE, GENERAL & INTERNAL | LEUCOVORIN | FIRE-3 | THERAPY | FOLFIRI PLUS CETUXIMAB | PHASE-II | IRINOTECAN | OXALIPLATIN | FLUOROURACIL | TUMORS | PROGRESSION | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Bevacizumab - therapeutic use | United States | Bevacizumab - adverse effects | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Cetuximab - therapeutic use | Cetuximab - adverse effects | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Camptothecin - administration & dosage | Female | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Kaplan-Meier Estimate | Treatment Outcome | Canada | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colorectal Neoplasms - secondary | Aged | Genes, ras | Organoplatinum Compounds - adverse effects | Chemotherapy | Usage | Care and treatment | Research | Colorectal cancer | Cancer | Drugs | Medical research | Colorectal carcinoma | Clinical trials | Cytotoxicity | Patients | Survival | K-Ras protein | Bevacizumab | Metastases | Survival analysis | Irinotecan | Randomization | Oxaliplatin | Monoclonal antibodies | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 19, pp. 1823 - 1833
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 13, pp. 1302 - 1308
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 22, pp. 2078 - 2092
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 2, pp. 138 - 148
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 1, pp. 23 - 34
Journal Article
Cancer, ISSN 0008-543X, 07/2012, Volume 118, Issue 13, pp. 3377 - 3386
Journal Article